Search

Sartorius Stedim Biotech.

Closed

SectorFinance

186.15 2.36

Overview

Share price change

24h

Current

Min

181.95

Max

187.45

Key metrics

By Trading Economics

Income

-23M

93M

Sales

400K

745M

P/E

Sector Avg

81.348

27.489

EPS

1.18

Dividend yield

0.37

Profit margin

12.43

Employees

10,030

EBITDA

-55M

201M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+21.68% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.37%

3.99%

Next Earnings

16 Oct 2025

Market Stats

By TradingEconomics

Market Cap

-1.2B

19B

Previous open

183.79

Previous close

186.15

News Sentiment

By Acuity

29%

71%

83 / 529 Finance

Technical Score

By Trading Central

Confidence

Bullish Evidence

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

14 Oct 2025, 22:33 UTC

Earnings

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 Oct 2025, 22:21 UTC

Major Market Movers

Dentsply Sirona Shares Rise After SEC Probe Ends

14 Oct 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 Oct 2025, 17:56 UTC

Major Market Movers

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 Oct 2025, 23:38 UTC

Market Talk

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 Oct 2025, 22:12 UTC

Market Talk
Earnings

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 Oct 2025, 21:40 UTC

Earnings

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 Oct 2025, 21:39 UTC

Earnings

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 Oct 2025, 21:38 UTC

Earnings

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 Oct 2025, 21:06 UTC

Earnings

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 Oct 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk
Earnings

Health Care Roundup: Market Talk

14 Oct 2025, 20:13 UTC

Earnings

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 Oct 2025, 20:01 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 Oct 2025, 19:21 UTC

Market Talk
Earnings

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 Oct 2025, 19:12 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 Oct 2025, 19:08 UTC

Market Talk

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 Oct 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 Oct 2025, 18:59 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 Oct 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 Oct 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 Oct 2025, 18:56 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 Oct 2025, 18:46 UTC

Earnings

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 Oct 2025, 18:04 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 Oct 2025, 18:01 UTC

Market Talk

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 Oct 2025, 17:54 UTC

Earnings

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 Oct 2025, 17:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 Oct 2025, 17:50 UTC

Market Talk

Lower Dollar Provides Some Strength in Grains -- Market Talk

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

21.68% upside

12 Months Forecast

Average 222.5 EUR  21.68%

High 240 EUR

Low 194 EUR

Based on 8 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

202.7 / 211.7Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

83 / 529 Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat